Skip to main content
Top

Cancer and Metastasis Reviews

Issue 4/2023

Metastasis Suppressor Genes: Mechanisms of Action and Therapeutic Approaches

Content (14 Articles)

Metastasis COMMENTARY

A perspective on the metastasis suppressor field

Imran Khan, Patricia S. Steeg

Preface

Mathieu Boissan

Open Access Metastasis REVIEW

Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics

Maxime Janin, Veronica Davalos, Manel Esteller

Open Access Metastasis Review

Epigenetic control of pancreatic cancer metastasis

Lukas Krauß, Carolin Schneider, Elisabeth Hessmann, Dieter Saur, Günter Schneider

Metastasis suppressor genes and their role in the tumor microenvironment

Cristina Megino-Luque, Jose Javier Bravo-Cordero

Open Access Metastasis

Mechanisms of action of NME metastasis suppressors – a family affair

Céline Prunier, Philippe Chavrier, Mathieu Boissan

Open Access Cancer of Unknown Primary NON-THEMATIC REVIEW

Carcinoma of unknown primary (CUP): an update for histopathologists

Katie Beauchamp, Bruce Moran, Timothy O’Brien, Donal Brennan, John Crown, Kieran Sheahan, Maura Bríd Cotter

Open Access Non-Thematic Review

Is cancer an intelligent species?

Chiara Nicolazzo, Federica Francescangeli, Valentina Magri, Alessandro Giuliani, Ann Zeuner, Paola Gazzaniga

Open Access Helicobacter Pylori Non-Thematic Review

Helicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development

Gracjana Krzysiek-Maczka, Tomasz Brzozowski, Agata Ptak-Belowska

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine